13,486 Shares in CME Group Inc. $CME Purchased by Union Bancaire Privee UBP SA

Key Points

• Union Bancaire Privee UBP SA acquired 13,486 shares of CME Group Inc., valued at approximately $3.7 million, as part of its new position in the company during the second quarter.
• CME Group reported an earnings per share (EPS) of $2.96 for the last quarter, exceeding analysts' expectations, with a notably high net margin of 58.48% and a revenue of $1.69 billion.
• The company recently announced a quarterly dividend of $1.25 per share, representing a 1.8% dividend yield and a payout ratio of 48.40%.

Union Bancaire Privee UBP SA acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,486 shares of the financial services provider's stock, valued at approximately $3,717,000.

Other hedge funds also recently modified their holdings of the company. Wayfinding Financial LLC acquired a new stake in shares of CME Group during the first quarter worth approximately $25,000. Webster Bank N. A. increased its holdings in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after buying an additional 60 shares in the last quarter. Cornerstone Planning Group LLC increased its holdings in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares in the last quarter. Highline Wealth Partners LLC increased its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 43 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its holdings in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Trading Up 0.7%

CME opened at $272.24 on Tuesday. The firm's fifty day moving average is $270.81 and its two-hundred day moving average is $271.14. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $98.11 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 4.89 and a beta of 0.43. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business posted $2.56 earnings per share. The firm's quarterly revenue was up 10.4% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group's payout ratio is presently 48.40%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $246.00 to $252.00 and gave the company an "underweight" rating in a research note on Thursday, September 25th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Oppenheimer increased their price target on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Finally, Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $268.14.

Insider Activity at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. The trade was a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business's stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company's stock, valued at $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is currently owned by corporate insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.